Medical Equipment

Cardiac Valve Market Analysis Highlighting Growth Potential And Outlook

April 10, 2026April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Cardiac Valve Market In 2026, And How Will Its Value Evolve By 2030?

The cardiac valve market has experienced substantial expansion in recent years. It is forecast to grow from $12.41 billion in 2025 to $14.24 billion in 2026, at a compound annual growth rate (CAGR) of 14.8%. This historical growth can be attributed to a rising incidence of valvular heart diseases, the expansion of cardiac surgery programs, a greater adoption of mechanical heart valves, advancements in surgical valve techniques, and the increasing availability of cardiac care facilities.

The cardiac valve market is projected to experience substantial growth over the next few years, with its size anticipated to reach $24.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.0%. This expansion during the forecast period can be attributed to several factors, including the increasing demand for transcatheter interventions, a growing emphasis on cardiac care for the elderly, the expansion of hybrid cardiac procedures, rising investments in next-generation valve technologies, and the broader adoption of patient-specific valve solutions. Significant trends expected in the forecast period encompass the increasing uptake of transcatheter valve procedures, a rising demand for bioprosthetic heart valves, a growing preference for minimally invasive valve replacement, the advancement of sophisticated valve repair techniques, and a heightened focus on valve durability and performance.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7753&type=smp

What Key Drivers Are Fueling The Growth Of The Cardiac Valve Market?

The increasing occurrence of cardiovascular conditions is projected to boost the expansion of the cardiac valve market. The widespread presence of cardiovascular ailments has steadily climbed, attributed to factors such as smoking, obesity, insufficient physical activity, and various other elements that burden the heart and blood vessels. The primary contributor to coronary artery disease involves the accumulation of fatty plaques within the arteries. This progressive rise in heart-related illnesses has consequently elevated the demand for cardiac valves used in treating heart valve issues. For instance, in October 2024, data from the Centers for Disease Control, a US-based government agency, indicated that in 2023, approximately 919,032 people succumbed to cardiovascular disease, representing 1 in every 3 deaths. Consequently, the escalating frequency of cardiovascular diseases is set to fuel the growth of the cardiac valve market.

Which Segments Define The Cardiac Valve Market Segment Structure?

The cardiac valve market covered in this report is segmented –

1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves

2) By Position: Aortic Valve, Mitral Valve, Other Positions

3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement

4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users

Subsegments:

1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves

2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves, Transcatheter Mitral Valve Replacement (TMVR) Valves

3) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves

What Trends Are Influencing The Cardiac Valve Market?

Leading companies within the cardiac valve market are prioritizing the development of technological advancements, such as transfemoral transcatheter mitral valve replacement (TMVR) systems, to address the increasing demand for minimally invasive therapies among an aging population experiencing a rise in mitral regurgitation cases. A transfemoral TMVR system employs a collapsible frame and biologic valve leaflets that can be introduced via a catheter through the femoral vein, thereby avoiding open-heart surgery and offering benefits like reduced recovery times, lower procedural risk, and greater suitability for patients who cannot undergo conventional surgery. For instance, in April 2025, Edwards Lifesciences, a U.S.-based medical device company, obtained CE Mark approval for its SAPIEN M3 System, which is the first transcatheter mitral valve replacement therapy delivered using a transfemoral approach. The SAPIEN M3 incorporates a docking mechanism that first secures the native mitral leaflets and chordae by drawing them inward to establish a stable landing zone, followed by the deployment of a bioprosthetic valve, with both stages delivered through a steerable 29 F guide sheath. This design allows for precise placement, repositioning, and retrieval before final deployment, thereby enhancing procedural safety and extending treatment options to patients unsuitable for surgery or edge-to-edge repair.

Who Are The Established Players Within The Cardiac Valve Market?

Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomédica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl

Get The Full Cardiac Valve Market Report:

https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

Which Region Leads The Cardiac Valve Market In Overall Market Size?

North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cardiac Valve Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=7753&type=smp

Browse Through More Reports Similar to the Global Cardiac Valve Market 2026, By The Business Research Company

Prosthetic Heart Valve Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Cardiovascular Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Cardiovascular Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795